IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, October 30, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced that the company has entered into an agency service agreement for SelectMDx® with Swiss-based Unilabs, one of Europe's leading providers of clinical laboratory testing and medical diagnostic imaging services.
Under the terms of the agreement, Unilabs medical laboratory in Geneva Switzerland, will perform SelectMDx service testing for all its clinical labs in France, Portugal, Sweden, Norway, Denmark, Finland, UK, Italy and Switzerland. To offer this service through its network, the laboratory will purchase SelectMDx CE-marked IVD kits from MDxHealth.
"We are excited that Unilabs is going to offer SelectMDx service testing to their customers," said Dr. Jan Groen, CEO, MDxHealth. "The company's broad hospital network and commercial capabilities will significantly contribute to the successful market penetration of SelectMDx."
"We are delighted to offer SelectMDx to Unilabs customers," commented Dr Pierre-Alain Menoud, Head of Molecular Diagnostics at Unilabs, Switzerland. "This agreement with MDxHealth reinforces our commitment to providing urologists with a service test."